Status:
COMPLETED
NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients
Lead Sponsor:
Case Comprehensive Cancer Center
Collaborating Sponsors:
Susan G. Komen Breast Cancer Foundation
Gilead Sciences
Conditions:
Breast Cancer
Prostate Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
African-Americans have disparately limited access to optimal cancer care. They have the highest overall cancer death rate and shortest survival time of any racial or ethnic group in the United States....
Eligibility Criteria
Inclusion
- Subjects must have histologically or cytologically confirmed Breast or Prostate Cancer.
- Subjects must be Age \>18 years. This study requires informed consent by the subject; as children are not able to perform this without parental approval, subjects \< age 18 are excluded from this study.
- Subjects must be of African - American race.
- Subjects must have the ability to understand and the willingness to sign a written informed consent document.
Exclusion
- Subjects NOT of African - American ethnicity.
- Subjects WITHOUT histologically or cytologically confirmed Breast or Prostate Cancer.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 3 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05978232
Start Date
July 1 2023
End Date
November 3 2025
Last Update
November 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States, 44106